FORMICOR PHARMACEUTICALS LTD

Overview

Company Name	FORMICOR PHARMACEUTICALS LTD
Company Status	Active
Legal Form	Private limited company
Company Number	16033908
Jurisdiction	England/Wales
Date of Creation	Oct 22, 2024

Summary

Has Super Secure PSCs	No
Has Charges	No
Has Insolvency History	No
Registered Office is in Dispute	No

What is the purpose of FORMICOR PHARMACEUTICALS LTD?

Manufacture of pharmaceutical preparations (21200) / Manufacturing
Other research and experimental development on natural sciences and engineering (72190) / Professional, scientific and technical activities

Where is FORMICOR PHARMACEUTICALS LTD located?

Registered Office Address	1 Benjamin Street EC1M 5QL London England
Undeliverable Registered Office Address	No

What are the latest accounts for FORMICOR PHARMACEUTICALS LTD?

Next Accounts
Overdue	Yes
Next Accounts Period End On	Oct 31, 2025
Next Accounts Due On	Jul 22, 2026

What is the status of the latest confirmation statement for FORMICOR PHARMACEUTICALS LTD?

Last Confirmation Statement
Last Confirmation Statement Made Up To	Oct 21, 2026
Next Confirmation Statement Due	Nov 04, 2026
Next Confirmation Statement Made Up To	Oct 21, 2025
Overdue	No

What are the latest filings for FORMICOR PHARMACEUTICALS LTD?

Filings

Date

Description

Document

Type

Nov 27, 2025

Confirmation statement made on Oct 21, 2025 with updates

4 pages

CS01

Apr 09, 2025

Particulars of variation of rights attached to shares

2 pages

SH10

Apr 09, 2025

Resolutions

Resolutions

4 pages

RESOLUTIONS

Resolutions
Category	Description	Type
capital	Resolution of allotment of securities	RES10
incorporation	Resolution of adoption of Articles of Association	RES01
capital	Resolution of removal of pre-emption rights	RES11

Apr 09, 2025

Memorandum and Articles of Association

46 pages

Apr 02, 2025

Change of details for Mr Simon Peter Bryson as a person with significant control on Mar 26, 2025

2 pages

PSC04

Apr 02, 2025

Statement of capital following an allotment of shares on Mar 26, 2025

Capital: GBP 16.4999

3 pages

SH01

Mar 31, 2025

Sub-division of shares on Mar 11, 2025

6 pages

SH02

Mar 31, 2025

Resolutions

Resolutions

2 pages

RESOLUTIONS

Resolutions
Category	Date	Description	Type
capital		Resolutions Re: sub-division 11/03/2025	RES13
capital		Resolution of removal of pre-emption rights	RES11

Mar 31, 2025

Resolutions

Resolutions

2 pages

RESOLUTIONS

Resolutions
Category	Date	Description	Type
capital		Resolutions Re: article 14(1) of the company's articles of association be dis-applied 11/03/2025	RES13

Mar 27, 2025

Appointment of Mr Simon Peter Bryson as a director on Mar 11, 2025

2 pages

AP01

Mar 25, 2025

Notification of Simon Peter Bryson as a person with significant control on Mar 11, 2025

2 pages

PSC01

Mar 25, 2025

Statement of capital following an allotment of shares on Mar 11, 2025

Capital: GBP 15

3 pages

SH01

Mar 25, 2025

Cessation of William James Peaker as a person with significant control on Mar 11, 2025

1 pages

PSC07

Mar 25, 2025

Termination of appointment of Christoph Oliver Ruedig as a director on Mar 11, 2025

1 pages

TM01

Mar 25, 2025

Termination of appointment of William James Peaker as a director on Mar 11, 2025

1 pages

TM01

Oct 22, 2024

Incorporation

12 pages

NEWINC

Associated Filings
Category	Date	Description	Type
incorporation	Oct 22, 2024	Model articles adopted	MODEL ARTICLES
capital	Oct 22, 2024	Statement of capital on Oct 22, 2024 Capital: GBP 1	SH01

View All Filings

Who are the officers of FORMICOR PHARMACEUTICALS LTD?

Officers
Name	Appointed On	Resigned On	Role	Address	Country of Residence	Nationality	Date of Birth	Number
BRODY, Leigh Pauline, Dr Benjamin Street EC1M 5QL London 1 England	Oct 22, 2024		Director	Benjamin Street EC1M 5QL London 1 England	England	American	1983-9	294709090001
BRYSON, Simon Peter One St. Peters Square M2 3DE Manchester Wework England	Mar 11, 2025		Director	One St. Peters Square M2 3DE Manchester Wework England	England	English	1968-11	333953580001
PEAKER, William James Benjamin Street EC1M 5QL London 1 England	Oct 22, 2024	Mar 11, 2025	Director	Benjamin Street EC1M 5QL London 1 England	England	British	1949-8	106990540001
RUEDIG, Christoph Oliver Benjamin Street EC1M 5QL London 1 England	Oct 22, 2024	Mar 11, 2025	Director	Benjamin Street EC1M 5QL London 1 England	England	British	1976-4	267177430001

View Detailed Information on Officers and People with Significant Control

Who are the persons with significant control of FORMICOR PHARMACEUTICALS LTD?

Persons with significant controls
Name	Notified On	Address	Ceased
Mr Simon Peter Bryson One St. Peters Square M2 3DE Manchester Wework England	Mar 11, 2025	One St. Peters Square M2 3DE Manchester Wework England	No
	Nationality: English Country of Residence: England
	Natures of Control The person holds, directly or indirectly, more than 75% of the shares in the company. The person holds, directly or indirectly, more than 50% but not more than 75% of the voting rights in the company.
Mr William James Peaker Benjamin Street EC1M 5QL London 1 England	Oct 22, 2024	Benjamin Street EC1M 5QL London 1 England	Yes
	Nationality: British Country of Residence: England
	Natures of Control The person holds, directly or indirectly, more than 75% of the shares in the company. The person holds, directly or indirectly, more than 75% of the voting rights in the company. The person holds the right, directly or indirectly, to appoint or remove a majority of the board of directors of the company.

View Detailed Information on Persons with Significant Control

Data Source

UK Companies House
The official register of companies in the UK, providing public access to company information such as names, addresses, directors, and financial filings.
license: CC0